Loss-of-function variants in ANGPTL3 were associated with lower plasma levels of lipids and lower rates of coronary disease. A monoclonal antibody against ANGPTL3 reduced the atherosclerotic lesion area in mice and reduced levels of triglycerides and LDL cholesterol in human volunteers. beach dresses for mother of the bride http://nej.md/2rhOEO5